150,000 Shares in Translational Development Acquisition Corp. (NASDAQ:TDACU) Purchased by Highbridge Capital Management LLC

Highbridge Capital Management LLC bought a new stake in Translational Development Acquisition Corp. (NASDAQ:TDACU) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 150,000 shares of the company’s stock, valued at approximately $2,766,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Calamos Advisors LLC bought a new stake in shares of Translational Development Acquisition in the fourth quarter valued at approximately $6,915,000. Wealthspring Capital LLC acquired a new position in Translational Development Acquisition during the 4th quarter valued at $1,095,000. Mizuho Securities USA LLC acquired a new position in Translational Development Acquisition during the 4th quarter valued at $2,305,000. Schechter Investment Advisors LLC bought a new stake in Translational Development Acquisition in the 4th quarter valued at $2,778,000. Finally, MMCAP International Inc. SPC acquired a new stake in Translational Development Acquisition in the 4th quarter worth $6,454,000.

Translational Development Acquisition Stock Performance

NASDAQ:TDACU opened at $10.19 on Friday. The stock’s 50-day moving average is $10.10. Translational Development Acquisition Corp. has a 52-week low of $10.00 and a 52-week high of $10.30.

Translational Development Acquisition Profile

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector.